Stay updated on Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page.

Latest updates to the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page
- Check2 days agoChange DetectedThe footer's displayed site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check9 days agoChange DetectedA site-wide NIH announcement was added about the website transition and the use of “Super Intelligence” alongside “Artificial Intelligence” during the transition.SummaryDifference0.5%

- Check16 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov interface as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check23 days agoChange DetectedThe record history now includes a version submitted on 2026-10-06, indicating that the study status was updated.SummaryDifference0.4%

- Check44 days agoChange DetectedA new revision entry v3.7.0 is added to the study's history. The prior revision v3.6.6 is removed from the listed changes.SummaryDifference0.1%

- Check65 days agoChange DetectedThe revision history now lists a new latest revision labeled v3.6.6, replacing the previous Revision: v3.6.5 entry in the history log. This reflects a minor page update rather than changes to study data.SummaryDifference0.1%

Stay in the know with updates to Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page.